Literature DB >> 24396022

Left ventricular strain and transmural distribution of structural remodeling in hypertensive heart disease.

Tomoko Ishizu1, Yoshihiro Seo, Yuri Kameda, Ryo Kawamura, Taizou Kimura, Nobutake Shimojo, Dongzhu Xu, Nobuyuki Murakoshi, Kazutaka Aonuma.   

Abstract

Left ventricular (LV) systolic wall strain is a new candidate for prognostic indicator of hypertensive heart failure. It remains unclear how underlying transmural structural remodeling corresponds to LV wall systolic deformation as hypertensive hypertrophy progresses. We fed 68 Dahl salt-sensitive rats a high-salt (hypertensive group) or low-salt diet (control group) from 6 weeks old. At 10, 14, and 18 weeks, pressure-volume relation, transmural distribution of LV fibrosis, and myocyte hypertrophy were evaluated. LV global longitudinal and circumferential strain was measured with speckle tracking echocardiography. Emax was preserved throughout the study period, whereas τ and end-diastolic pressure-volume relation progressively deteriorated from 14 weeks (diastolic dysfunction stage). Lung weight increased significantly at 18 weeks (decompensated stage). Histological percentage area fibrosis and collagen type I/III, myocyte hypertrophy, and α-myosin heavy chain isoform increased in the subendocardial layer at 14 weeks and progressed into the midlayer at 18 weeks. Longitudinal strain progressively deteriorated in the hypertensive group versus control group at 14 weeks (hypertensive group: -17±3%, control: -27±4%; P<0.001), and circumferential strain decreased at 18 weeks (hypertensive group: -17±2%, control: -27±3%; P=0.002). After adjustment for systolic wall stress, subendocardial percentage area fibrosis was selected as the independent determinant of longitudinal strain. This study showed that LV wall strain alternations were accompanied by fibrosis and myocyte hypertrophy from subendocardium to epicardium, and longitudinal strain related significantly to subendocardial layer fibrosis. Longitudinal strain could be a surrogate of subendocardial fibrotic changes and may be useful for risk stratification of hypertensive heart failure.

Entities:  

Keywords:  echocardiography; heart failure; hypertension; hypertrophy; myocardial contraction

Mesh:

Year:  2014        PMID: 24396022     DOI: 10.1161/HYPERTENSIONAHA.113.02149

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  52 in total

1.  Quantitative assessment of myocardial fibrosis in an age-related rat model by ex vivo late gadolinium enhancement magnetic resonance imaging with histopathological correlation.

Authors:  Pascale Beliveau; Farida Cheriet; Stasia A Anderson; Joni L Taylor; Andrew E Arai; Li-Yueh Hsu
Journal:  Comput Biol Med       Date:  2015-08-08       Impact factor: 4.589

2.  Prognostic Implications of Mitral Annular Plane Systolic Excursion in Patients with Hypertension and a Clinical Indication for Cardiac Magnetic Resonance Imaging: A Multicenter Study.

Authors:  Simone Romano; Robert M Judd; Raymond J Kim; Han W Kim; John F Heitner; Dipan J Shah; Richard B Devereux; Pablo Salazar; Michael Trybula; Richard C Chia; Kaleigh Evans; Afshin Farzaneh-Far
Journal:  JACC Cardiovasc Imaging       Date:  2018-11-05

3.  Challenges for 'diastology': contributions from Japanese researchers.

Authors:  Takashi Oki; Hirokazu Miyoshi; Yoshifumi Oishi; Yukio Mizuguchi; Arata Iuchi; Hirotsugu Yamada; Satoshi Nakatani
Journal:  J Echocardiogr       Date:  2016-08-18

4.  Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice.

Authors:  Grace Casaclang-Verzosa; Maurice Enriquez-Sarano; Hector R Villaraga; Jordan D Miller
Journal:  J Vis Exp       Date:  2017-02-14       Impact factor: 1.355

5.  Application of a combination of echocardiographic techniques in an experimental model of epirubicin-induced cardiotoxicity.

Authors:  Liangliang Bi; Huaxing Zhang; Ruoling Han; Wei Chen; Na Zhao
Journal:  Int J Cardiovasc Imaging       Date:  2020-02-07       Impact factor: 2.357

6.  Race-ethnic differences in subclinical left ventricular systolic dysfunction by global longitudinal strain: A community-based cohort study.

Authors:  Cesare Russo; Zhezhen Jin; Shunichi Homma; Tatjana Rundek; Mitchell S V Elkind; Ralph L Sacco; Marco R Di Tullio
Journal:  Am Heart J       Date:  2015-02-21       Impact factor: 4.749

7.  2D speckle-tracking TTE-based quantitative classification of left ventricular myocardium in patients with hypertrophic cardiomyopathy by the presence or the absence of fibrosis and/or hypertrophy.

Authors:  Nobusada Funabashi; Hiroyuki Takaoka; Koya Ozawa; Masae Uehara; Issei Komuro; Yoshio Kobayashi
Journal:  Heart Vessels       Date:  2018-03-22       Impact factor: 2.037

8.  Ambulatory Blood Pressure Control and Subclinical Left Ventricular Dysfunction in Treated Hypertensive Subjects.

Authors:  Fusako Sera; Zhezhen Jin; Cesare Russo; Edward S Lee; Joseph E Schwartz; Tatjana Rundek; Mitchell S V Elkind; Shunichi Homma; Ralph L Sacco; Marco R Di Tullio
Journal:  J Am Coll Cardiol       Date:  2015-09-22       Impact factor: 24.094

9.  Utility of strain-echocardiography in current clinical practice.

Authors:  Kaoru Dohi; Emiyo Sugiura; Masaaki Ito
Journal:  J Echocardiogr       Date:  2016-03-02

10.  Relationship of Office and Ambulatory Blood Pressure With Left Ventricular Global Longitudinal Strain.

Authors:  Fusako Sera; Zhezhen Jin; Cesare Russo; Edward S Lee; Joseph E Schwartz; Tatjana Rundek; Mitchell S V Elkind; Shunichi Homma; Ralph L Sacco; Marco R Di Tullio
Journal:  Am J Hypertens       Date:  2016-11-01       Impact factor: 2.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.